normal phase hplc Search Results


90
Chiral Technologies Europe chiral normal-phase hplc columns (250×4.6 chiralpak as-h)
Chiral Normal Phase Hplc Columns (250×4.6 Chiralpak As H), supplied by Chiral Technologies Europe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/us09796703-280-0-9?v=Chiral+Technologies+Europe
Average 90 stars, based on 1 article reviews
chiral normal-phase hplc columns (250×4.6 chiralpak as-h) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Maisch GmbH semipreparative hplc with a normal phase si-column with si reprosil 100
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Semipreparative Hplc With A Normal Phase Si Column With Si Reprosil 100, supplied by Maisch GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/pmc10666548-218-15-33?v=Maisch+GmbH
Average 90 stars, based on 1 article reviews
semipreparative hplc with a normal phase si-column with si reprosil 100 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Denka Co Ltd hplc normal phase column nh2p50-e
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Hplc Normal Phase Column Nh2p50 E, supplied by Denka Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1074_slash_jbc__m110__206722-102-9-13?v=Denka+Co+Ltd
Average 90 stars, based on 1 article reviews
hplc normal phase column nh2p50-e - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MedImmune llc normal phase high pressure liquid chromatography np-hplc 2-ab
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase High Pressure Liquid Chromatography Np Hplc 2 Ab, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1016_slash_j__cherd__2013__04__002-62-70-6?v=MedImmune+llc
Average 90 stars, based on 1 article reviews
normal phase high pressure liquid chromatography np-hplc 2-ab - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Younglin Instrument Co Ltd normal phase hplc
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase Hplc, supplied by Younglin Instrument Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1016_slash_j__foodchem__2012__02__138-60-10-13?v=Younglin+Instrument+Co+Ltd
Average 90 stars, based on 1 article reviews
normal phase hplc - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
DIACK Inc normal phase high performance liquid chromatography (hplc)
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase High Performance Liquid Chromatography (Hplc), supplied by DIACK Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1016_slash_j__jcs__2019__05__019-15-9-24?v=DIACK+Inc
Average 90 stars, based on 1 article reviews
normal phase high performance liquid chromatography (hplc) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Pharmacia LKB Biotechnology Inc hplc normal phase column, s10w, 64,340 plates/meter
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Hplc Normal Phase Column, S10w, 64,340 Plates/Meter, supplied by Pharmacia LKB Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1016_slash_j__tet__2007__12__007-105-32-6?v=Pharmacia+LKB+Biotechnology+Inc
Average 90 stars, based on 1 article reviews
hplc normal phase column, s10w, 64,340 plates/meter - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
RStech Corp normal-phase silica hplc column sil-m51001546
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase Silica Hplc Column Sil M51001546, supplied by RStech Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1007_slash_s11694___020___00712___w-86-6-20?v=RStech+Corp
Average 90 stars, based on 1 article reviews
normal-phase silica hplc column sil-m51001546 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Pharmacia Upjohn LLC column-switching, normal-phase hplc system
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Column Switching, Normal Phase Hplc System, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/pm07828385-83-22-10?v=Pharmacia+Upjohn+LLC
Average 90 stars, based on 1 article reviews
column-switching, normal-phase hplc system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Senshu Scientific Co Ltd normal phase hplc silica-2150-n column
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase Hplc Silica 2150 N Column, supplied by Senshu Scientific Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/pm33857621-46-34-36?v=Senshu+Scientific+Co+Ltd
Average 90 stars, based on 1 article reviews
normal phase hplc silica-2150-n column - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Western Analytical Inc normal phase hplc poly-hydroxyethyl hilic
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase Hplc Poly Hydroxyethyl Hilic, supplied by Western Analytical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/pm14675762-54-24-29?v=Western+Analytical+Inc
Average 90 stars, based on 1 article reviews
normal phase hplc poly-hydroxyethyl hilic - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Altech Inc normal phase silica preparative hplc column
Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase <t>HPLC</t> (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).
Normal Phase Silica Preparative Hplc Column, supplied by Altech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+phase+hplc/10__1139_slash_v00___068-192-24-23?v=Altech+Inc
Average 90 stars, based on 1 article reviews
normal phase silica preparative hplc column - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase HPLC (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).

Journal: Environment international

Article Title: Identification of the bacterial metabolite aerugine as potential trigger of human dopaminergic neurodegeneration

doi: 10.1016/j.envint.2023.108229

Figure Lengend Snippet: Purification of neurotoxic small molecules from Streptomyces bacterial strains. A Workflow of metabolite identification from bacterial extracts. Subfigures that provide activity data on the respective purification stages are indicated. Information on the purification procedures is given in the subfigure paragraphs below. B-E The neurotoxicity of extracts, fractions and pure compounds was tested on human dopaminergic neurons. After 6 days of differentiation (d6), cultures of LUHMES neurons were exposed to bacterial fractions. The cell viability was assessed by calcein-AM & H-33342 staining, automated fluorescence microscopy and quantification by an image processing algorithm. B Cultures of Streptomyces venezuelae and S. lividans were extracted with ethyl acetate (EA) or dichloromethane (DCM). The crude extracts were fractionated via Sep-Pak C18 and eluted using a stepwise gradient with methanol and water (MeOH = 60% or 100%). Dried and DMSO-reconstituted fractions were tested for effects on neuronal viability. Data from at least two fully independent runs. Viability data was obtained after 24 h of exposure. C The EA/60% MeOH extract of S. venezuelae was further fractionated by reverse phase HPLC (C18 column, MeOH gradient). The collected fractions are indicated in the absorption spectrum (a part of the spectrum is shown, the full spectrum is given in ; the MeOH gradient started at 50%). Fractions were dried, taken up in DMSO and added to neurons for 48 h (final dilution 1:1000). Viability data are means ± SEM (n = 3). D Fraction 14 of the previous step was further purified by several reverse phase HPLC (C-18) runs in acetonitrile/water eluent. Absorption peaks were collected in fractions as depicted (red numbers in the spectrum). They were tested for their effect on neuronal viability (24 h, at 1:1000 and 1:10000 dilutions). E Two single substances (aerugine and aeruginol) of fraction 4 of the previous purification step were separated and purified to homogeneity. The chemical structures (elucidation details in and spectral data 1) are displayed next to their respective peaks in the elution trail diagram. Note the additional double bond in the thiazolidine ring of aeruginol. The two compounds were assessed in two separate experiments for their effect on neuronal viability after incubation times of 24 h and 48 h. All statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test (** = p < 0.005, *** = p < 0.0001).

Article Snippet: Automated flash chromatography with 1:1 hexane:EA yielded a semi-pure product, which was further purified with semipreparative HPLC with a normal phase Si-column with Si Reprosil 100 (250 × 10 mm, 5 μm, Dr. Maisch).

Techniques: Purification, Activity Assay, Staining, Fluorescence, Microscopy, Incubation